Nassauer K A
Robert Koch-Institut, Berlin.
Gesundheitswesen. 1996 Nov;58(11):616-7.
In Oct. 1995, the National Committee for Immunisation at the Robert Koch-Institute recommended general hepatitis B vaccination for all infants as well as adolescents between 13 to 15 years of age. With an incidence of 50,000 cases per year, hepatitis B (HB) is the most common vaccine-preventable disease in Germany. Sexual contacts are the primary means of transmission of HB. Because of this fact, young adolescents are an important target group for a national HB vaccination programme. Having only few contacts to physicians in private clinics, these adolescents may accept this vaccination after intelligent and long-term health-campaigns. In the present situation, we are running out of time. To reach all targeted adolescents, we need activities by public-health offices having regular contacts with school classes only when immunizing all girls against rubella at the age of 11 to 15. This provides an ideal opportunity to immunise against HB as well. Substantial support seems possible if HB is clearly recognized as a serious emerging infectious disease in Germany.
1995年10月,罗伯特·科赫研究所的国家免疫委员会建议对所有婴儿以及13至15岁的青少年进行普遍的乙型肝炎疫苗接种。乙型肝炎(HB)在德国每年发病5万例,是最常见的可通过疫苗预防的疾病。性接触是HB的主要传播途径。鉴于此,青少年是全国HB疫苗接种计划的重要目标群体。这些青少年在私人诊所与医生接触较少,可能会在开展明智且长期的健康宣传活动后接受这种疫苗接种。就目前情况而言,我们时间紧迫。为了覆盖所有目标青少年,我们需要公共卫生部门开展相关活动,而公共卫生部门仅在为11至15岁的所有女孩接种风疹疫苗时才会定期与学校班级接触。这也为接种HB疫苗提供了理想机会。如果HB在德国被明确认定为一种严重的新出现的传染病,似乎有可能获得大量支持。